Join POLITICO’s AgencyIQ research team on November 10th at 12 pm EST as we discuss what the results (or pending results) of the Presidential and Congressional elections mean for the FDA, including key priorities and initiatives.
We will also take a closer look at the continued impact of COVID-19 on the FDA and how companies can best prepare themselves for 2021. Attendees will leave this webinar with:
· Understanding of key regulatory and policy priorities, shifts, and goals coming out of the FDA through year end and into early 2021,
· More clarity on what a transition or stay in Administration means for their organization, and
· Insights into how their organization can avoid COVID-related compliance issues.
Joining the webinar will be AgencyIQ Head of Research Alexander Gaffney, MS, RAC, Senior Research Managers Laura DiAngelo, MPH and Kedest Tadesse, MS, RAC, and a to-be-determined member of POLITICO’s health care news team.